Suppliers and packagers for CHG SCRUB

CHG SCRUB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	Henry Schein, Inc.	0404-0175-02	946 mL in 1 BOTTLE (0404-0175-02)	2021-11-17
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	Henry Schein, Inc.	0404-0176-09	3785 mL in 1 BOTTLE (0404-0176-09)	2021-11-17
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	SC Johnson Professional USA, Inc.	11084-126-03	118 mL in 1 BOTTLE (11084-126-03)	2019-11-15
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	SC Johnson Professional USA, Inc.	11084-128-03	118 mL in 1 BOTTLE (11084-128-03)	2019-08-15
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	SC Johnson Professional USA, Inc.	11084-128-24	946 mL in 1 BOTTLE (11084-128-24)	2019-08-15
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	Rising Pharma Holdings, Inc.	16571-111-12	118 mL in 1 BOTTLE (16571-111-12)	2023-07-26
Ecolab	CHG SCRUB	chlorhexidine gluconate	SOLUTION;TOPICAL	019258	NDA	Rising Pharma Holdings, Inc.	16571-111-24	237 mL in 1 BOTTLE (16571-111-24)	2023-07-26

Suppliers for the Pharmaceutical Drug: CHG Scrub

Last updated: July 30, 2025

Introduction

Chlorhexidine Gluconate (CHG) Scrub is a highly specialized antiseptic solution widely used in healthcare settings for skin disinfection prior to surgical procedures, invasive device placement, and other aseptic tasks. As a critical component in infection control protocols, the demand for CHG Scrub has surged, emphasizing the importance of reliable suppliers capable of maintaining high-quality standards and regulatory compliance. This article provides a comprehensive overview of key suppliers involved in the manufacturing and distribution of CHG Scrub, analyzing their market positioning, manufacturing capabilities, and strategic advantages.

Overview of Chlorhexidine Gluconate (CHG) and Its Formulations

Chlorhexidine gluconate is a broad-spectrum antimicrobial agent effective against Gram-positive and Gram-negative bacteria, fungi, and some viruses. Its incorporation into topical antiseptic formulations, notably CHG Scrub, supports infection prevention in various clinical settings. Typically, CHG Scrub solutions are available in alcohol-based and aqueous forms, with the latter favored for patients with sensitivities, and the former preferred for rapid antimicrobial activity.

Manufacturers and suppliers must adhere to stringent quality controls, such as Good Manufacturing Practices (GMP), and obtain regulatory approvals from agencies like the FDA (Food and Drug Administration) and EMA (European Medicines Agency). This compliance ensures product safety, efficacy, and consistency across batches.

Leading Suppliers of CHG Scrub

1. 3M Healthcare

Overview:
3M is a global leader in healthcare products, including antiseptic solutions. Their CHG-based products, marketed under their Scientific and Healthcare divisions, are widely used in hospitals. The company emphasizes innovation, quality assurance, and extensive distribution networks.

Manufacturing Capabilities:
3M produces CHG formulations at multiple facilities globally, leveraging proprietary manufacturing processes to ensure stability, potency, and safety. Their supply chain integrates rigorous quality management systems aligned with ISO standards.

Strategic Advantages:

• Extensive R&D infrastructure enabling continuous product improvement
• Global reach ensuring reliable supply for multinational healthcare providers
• Proven compliance with regulatory standards

2. Henkel (Luitpold Pharmaceuticals)

Overview:
Henkel’s antiseptic segment, through its healthcare division, supplies a range of chlorhexidine solutions, including CHG Scrub formulations. Their products are well-established in hospital markets worldwide.

Manufacturing Capabilities:
Henkel operates manufacturing plants compliant with GMP, producing sterile antiseptics that meet international standards. Their portfolio includes alcohol-based CHG solutions designed for rapid action.

Strategic Advantages:

• Strong presence in European and North American markets
• Extensive certifications and regulatory approvals
• Focus on product stability and patient safety

3. Teleflex Incorporated

Overview:
Teleflex provides medical devices and solutions, including antiseptic products. Their CHG Scrub formulations focus on infection prevention, especially in surgical and critical-care environments.

Manufacturing Capabilities:
Teleflex’s manufacturing facilities adhere to strict quality standards, with capabilities for large-scale sterile production. Their products are engineered for ease of use and maximum efficacy.

Strategic Advantages:

• Integrated supply chain minimizing stock shortages
• Focused innovation in infection prevention technologies
• Strong clinician relationships enhancing product adoption

4. Ecolab Inc.

Overview:
Ecolab, a leader in infection prevention and health safety, supplies chlorhexidine-based antiseptics, including CHG Scrubs. Their products are used in hospitals, outpatient settings, and long-term care facilities.

Manufacturing Capabilities:
Ecolab operates multiple GMP-certified manufacturing plants globally. Their formulations are often included in comprehensive infection control solutions incorporating hand hygiene and surface disinfectants.

Strategic Advantages:

• Integrated approach to infection control
• Extensive educational and support services for customers
• Robust logistics network for timely distribution

5. Pfizer Inc.

Overview:
Pfizer, renowned for its pharmaceutical portfolio, manufactures chlorhexidine solutions, often in partnership with regional distributors. Their chlorhexidine products meet rigorous standards and are widely trusted.

Manufacturing Capabilities:
Pfizer’s manufacturing footprint is extensive, with numerous GMP-compliant facilities. They focus on high-quality antiseptic solutions suitable for sterile preparations.

Strategic Advantages:

• Established global presence and brand recognition
• Strong regulatory track record
• Capacity to scale production rapidly to meet demand surges

Emerging and Specialty Suppliers

In addition to global industry leaders, several regional and specialty manufacturers focus on niche markets or certain formulations of CHG Scrub:

• Baxter International – Offers chlorhexidine solutions in various healthcare settings, emphasizing sterile processing.
• ConvaTec – Supplies chlorhexidine-based products tailored to wound care and skin antisepsis.
• Reckitt Benckiser (formerly part of Reckitt Health) – Known for antiseptic skin cleansers, including chlorhexidine preparations for various uses.

These suppliers often serve local markets, supply to niche sectors, or innovate on formulations for enhanced skin tolerability.

Supply Chain and Regulatory Considerations

The supply chain integrity for CHG Scrub is critical, given the product’s role in infection prevention. Manufacturers must guarantee:

• Compliance: Adherence to GMP standards and regulatory approvals from agencies like the FDA (e.g., NDA or ANDA approvals for chlorhexidine antiseptics) and EMA.
• Quality Control: Stringent testing of raw materials, sterilization processes, and final product validation.
• Supply Security: Diversification of manufacturing sites to mitigate risks related to political, environmental, or pandemic-related disruptions.

In recent periods, supply chain constraints, especially amid COVID-19, have underscored the importance of multiple sourcing strategies and inventory management.

Strategic Market Dynamics

The demand for CHG Scrub continues to grow, driven by enhanced infection control protocols across healthcare systems globally. Key market dynamics include:

• Regulatory Approvals: Some markets now require preapproval or enhanced safety data for antiseptics, influencing supplier offerings.
• Patent Expirations: As certain formulations become off-patent, new entrants emerge, increasing competition.
• Innovations: Development of chlorhexidine formulations with improved skin tolerability, longer-lasting activity, and compatibility with various clinical procedures.

Conclusion

The landscape for CHG Scrub suppliers is characterized by a combination of established multinational corporations, regional manufacturers, and emerging innovative players. Market leaders such as 3M, Henkel, Teleflex, Ecolab, and Pfizer dominate due to their extensive manufacturing capabilities, regulatory expertise, and global distribution networks. Healthcare providers and procurement agencies prioritizing high-quality, compliant, and reliable supply chains prefer these suppliers, especially amid rising infection control standards.

Leveraging supplier diversity and ensuring strict adherence to regulatory and quality standards will remain critical for stakeholders seeking to optimize infection prevention strategies with CHG Scrub formulations.

---

Key Takeaways

• Global leaders like 3M, Henkel, Teleflex, Ecolab, and Pfizer dominate the CHG Scrub market due to their robust manufacturing and regulatory compliance.
• Ensuring supply chain resilience is vital amid increasing demand and possible disruptions.
• Regulatory approvals and GMP compliance are non-negotiable for high-quality infection prevention products.
• Innovation in formulations, particularly for skin tolerability and long-lasting efficacy, is shaping supplier competitiveness.
• Regional suppliers and niche manufacturers can offer tailored solutions but may face scalability challenges.

---

Frequently Asked Questions

Q1: What factors should healthcare providers consider when selecting a CHG Scrub supplier?
A: Providers should assess product quality, regulatory compliance, supplier reliability, supply chain robustness, and compatibility with clinical protocols. Certification standards like GMP and FDA/EMA approvals are critical.

Q2: Are there regional differences in CHG Scrub formulations?
A: Yes. Formulations vary to meet local regulatory requirements, preferences for alcohol-based versus aqueous solutions, and specific patient safety considerations. Suppliers often adapt products to regional standards.

Q3: How do regulatory agencies impact CHG Scrub manufacturing and distribution?
A: Agencies like the FDA and EMA enforce rigorous standards for safety, efficacy, and manufacturing quality. Approved suppliers must demonstrate compliance with these standards to continue distribution.

Q4: What are the main challenges faced by CHG Scrub suppliers?
A: Key challenges include raw material sourcing, regulatory hurdles, manufacturing scale-up, maintaining product stability, and supply chain disruptions.

Q5: How is the market for CHG Scrub expected to evolve in the next five years?
A: Market growth is anticipated driven by increasing infection control protocols, innovations in formulations, and expanding healthcare infrastructure, with suppliers investing in R&D to develop improved, skin-friendly products.

---

References

[1] U.S. Food and Drug Administration. "Antiseptic Drug Products: Currently Approved Active Ingredients." FDA.

[2] European Medicines Agency. "Guidelines on the Quality of Medicinal Products Containing Chlorhexidine."

[3] 3M Healthcare. "Product Portfolio and Manufacturing Standards." 3M Corporate Website.

[4] Henkel Corporate. "Healthcare Solutions and Quality Certifications." Henkel.

[5] Ecolab. "Infection Prevention Solutions and Supply Chain Logistics." Ecolab Corporate Reports.